title: The identification of microRNAs in a genomically unstable region of human chromosome 8q24.
abstract: The PVT1 locus is identified as a cluster of T(2;8) and T(8;22) "variant" MYC-activating chromosomal translocation breakpoints extending 400 kb downstream of MYC in a subset (approximately 20%) of Burkitt's lymphoma (vBL). Recent reports that microRNAs (miRNA) may be associated with fragile sites and cancer-associated genomic regions prompted us to investigate whether the PVT1 region on chromosome 8q24 may contain miRNAs. Computational analysis of the genomic sequence covering the PVT1 locus and experimental verification identified seven miRNAs. One miRNA, hsa-miR-1204, resides within a previously described PVT1 exon (1b) that is often fused to the immunoglobulin light chain constant region in vBLs and is present in high copy number in MYC/PVT1-amplified tumors. Like its human counterpart, mouse mmu-miR-1204 represents the closest miRNA to Myc (~50 kb) and is found only 1 to 2 kb downstream of a cluster of retroviral integration sites. Another miRNA, mmu-miR-1206, is close to a cluster of variant translocation breakpoints associated with mouse plasmacytoma and exon 1 of mouse Pvt1. Virtually all the miRNA precursor transcripts are expressed at higher levels in late-stage B cells (including plasmacytoma and vBL cell lines) compared with immature B cells, suggesting possible roles in lymphoid development and/or lymphoma. In addition, lentiviral vector-mediated overexpression of the miR-1204 precursor (human and mouse) in a mouse pre-B-cell line increased expression of Myc. High levels of expression of the hsa-miR-1204 precursor is also seen in several epithelial cancer cell lines with MYC/PVT1 coamplification, suggesting a potentially broad role for these miRNAs in tumorigenesis.
authors.affiliation: Gene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA. huppi@helix.nih.gov
authors.forename: Konrad
authors.initials: K
authors.lastname: Huppi
authors.forename: Natalia
authors.initials: N
authors.lastname: Volfovsky
authors.forename: Timothy
authors.initials: T
authors.lastname: Runfola
authors.forename: Tamara L
authors.initials: TL
authors.lastname: Jones
authors.forename: Mark
authors.initials: M
authors.lastname: Mackiewicz
authors.forename: Scott E
authors.initials: SE
authors.lastname: Martin
authors.forename: J Frederic
authors.initials: JF
authors.lastname: Mushinski
authors.forename: Robert
authors.initials: R
authors.lastname: Stephens
authors.forename: Natasha J
authors.initials: NJ
authors.lastname: Caplen
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000378:metabolism; D001483:Base Sequence; D015152:Blotting, Northern; D002460:Cell Line; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D019295:Computational Biology; D018628:Gene Dosage; D015894:Genome, Human / Q000235:genetics; D042822:Genomic Instability / Q000235:genetics*; D006801:Humans; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D008969:Molecular Sequence Data; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D012322:RNA Precursors / Q000235:genetics / Q000378:metabolism; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014161:Transduction, Genetic
chemical_list: D035683:MicroRNAs; D016271:Proto-Oncogene Proteins c-myc; D012322:RNA Precursors